These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 18671662
21. [Therapeutic effect and pharmacokinetics of transdermal phenazepam preparation in patients with different anxiety disorders]. Dorofeeva OA, Siuniakov SA, Zherdev VP, Kolyvanov GB, Litvin AA, Neznamov GG. Eksp Klin Farmakol; 2009; 72(2):6-10. PubMed ID: 19441719 [Abstract] [Full Text] [Related]
22. Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology. Nelson J, Chouinard G. Can J Clin Pharmacol; 1999; 6(2):69-83. PubMed ID: 10519733 [Abstract] [Full Text] [Related]
23. Adverse effects of benzodiazepines in psychiatric outpatients. Arbanas G, Arbanas D, Dujam K. Psychiatr Danub; 2009 Mar; 21(1):103-7. PubMed ID: 19270632 [Abstract] [Full Text] [Related]
31. Pregabalin: new indication. Generalised anxiety: better to use benzodiazepine. Prescrire Int; 2007 Jun 14; 16(89):104. PubMed ID: 17582925 [Abstract] [Full Text] [Related]
32. Prospective cohort study into post-disaster benzodiazepine use demonstrated only short-term increase. Dorn T, Yzermans CJ, van der Zee J. J Clin Epidemiol; 2007 Aug 14; 60(8):795-802. PubMed ID: 17606175 [Abstract] [Full Text] [Related]
33. [Benzodiazepines in the treatment of catatonia]. Van Dalfsen AN, Van Den Eede F, Van Den Bossche B, Sabbe BG. Tijdschr Psychiatr; 2006 Aug 14; 48(3):235-9. PubMed ID: 16956088 [Abstract] [Full Text] [Related]
35. Psychomotor performance following the long-term use of benzodiazepines. Lucki I, Rickels K, Geller AM. Psychopharmacol Bull; 1985 Aug 14; 21(1):93-6. PubMed ID: 2858909 [No Abstract] [Full Text] [Related]
36. Use and misuse of benzodiazepines in the elderly. Burch EA. Psychiatr Med; 1990 Aug 14; 8(2):97-105. PubMed ID: 1970664 [No Abstract] [Full Text] [Related]
37. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, den Boer JA, Fineberg NA, Knapp M, Scott J, Wittchen HU, British Association for Psychopharmacology. J Psychopharmacol; 2005 Nov 14; 19(6):567-96. PubMed ID: 16272179 [Abstract] [Full Text] [Related]